Skip to main content
. 2020 Dec 11;55(Suppl 1):181–714. doi: 10.1038/s41409-020-01120-w
Uninterrupted procedure (n=34) Standart procedure (n=28) p
Mobilization n(%) G-CSF G-CSF+Plerixofar 19 (67.9) 9(32.1) 19(55.9) 15(44.1) NS
İnfused CD34+ cell (medianx10e6/kg) 4.5 (3.3-6.2) 4(3.0-5.4) NS
Day of neuthrophil engraftment (median day) 12(8-17) 12(11-18) NS
Day of platelet engraftment (median day) 13(8-22) 12(10-20) NS
Transfusion requirement (median U) Erytrocyte Platelet 1(1-8) 3(1-8) 1(0-7) 2(0-9) NS
Catheter infection n(%) 2(5.8) 2(7.1) NS
Febril neuthropenia n(%) 13(38.2) 13(46.4) NS
Engraftment syndrome n(%) 4(11.7) 8(28.5) NS
Graft dysfunction n(%) 2 (5.8) 3 (10.7) NS